Last update 29 May 2025

NeoAntigen Tumor Vaccine(Shanghai Houchao Biotechnology)

Overview

Basic Info

Drug Type
Personalized antigen vaccine, Therapeutic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Adenocarcinoma of LungNon-small cell lung cancer stage IIIA
Inactive Indication-
Originator Organization
Shanghai Houchao Biotechnology Co., Ltd.Shanghai Houchao Biotechnology Co., Ltd.
Active Organization
Hunan Cancer HospitalHunan Cancer HospitalShanghai Houchao Biotechnology Co., Ltd.Shanghai Houchao Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NeoAntigen Tumor Vaccine(Shanghai Houchao Biotechnology)
NCT03807102
/ Not yet recruitingPhase 1/2IIT
Phase I/II Trial of Tumor Vaccine in Post Radical Operation Patients With Lung Cancer
100 Clinical Results associated with NeoAntigen Tumor Vaccine(Shanghai Houchao Biotechnology)
Login to view more data
100 Translational Medicine associated with NeoAntigen Tumor Vaccine(Shanghai Houchao Biotechnology)
Login to view more data
100 Patents (Medical) associated with NeoAntigen Tumor Vaccine(Shanghai Houchao Biotechnology)
Login to view more data
100 Deals associated with NeoAntigen Tumor Vaccine(Shanghai Houchao Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenocarcinoma of LungPhase 2
China
Hunan Cancer HospitalHunan Cancer Hospital
16 Jan 2024
Adenocarcinoma of LungPhase 2
China
Shanghai Houchao Biotechnology Co., Ltd.Shanghai Houchao Biotechnology Co., Ltd.
16 Jan 2024
Non-small cell lung cancer stage IIIAPhase 2
China
Hunan Cancer HospitalHunan Cancer Hospital
16 Jan 2024
Non-small cell lung cancer stage IIIAPhase 2
China
Shanghai Houchao Biotechnology Co., Ltd.Shanghai Houchao Biotechnology Co., Ltd.
16 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free